Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Biological Variation of insulin resistance in normal ovulating women and PolyCystic Ovarian Syndrome
ISRCTN ISRCTN65353256
ClinicalTrials.gov identifier
Public title Biological Variation of insulin resistance in normal ovulating women and PolyCystic Ovarian Syndrome
Scientific title
Acronym Biological variation in PCOS
Serial number at source 02/98/249
Study hypothesis Women with polycystic ovarian syndrome has a higher and more variable insulin resistance than controls
Ethics approval Hull and East Riding Local Research Ethics Committee. LREC number : 02/98/249
Study design Comparison study
Countries of recruitment United Kingdom
Disease/condition/study domain Polycystic ovarian syndrome
Participants - inclusion criteria The diagnosis of PCOS will be based on evidence of hyperandrogenemia (Free androgen index > 8, with a history of oligomenorrhea and hirsutism or acne. Non classical 21-hydroxylase deficiency, hyperprolactinemia, and androgen secreting tumors will be excluded by appropriate tests before the diagnosis of PCOS will be made. Transvaginal ultrasound will also be performed to confirm the diagnosis of PCOS
Participants - exclusion criteria 1. No subjects will be taking any medication currently or for the preceding six months
2. No concurrent illness
3. Patients not wishing to allow disclosure to their GPs
Anticipated start date 28/02/2002
Anticipated end date 31/12/2004
Status of trial Completed
Patient information material
Target number of participants 40
Interventions Primary outcome was the comparison of insulin resistance in polycystic ovarian syndrome and controls. Venous blood was taken for measurement of insulin and glucose levels, and insulin resistance was calculated by HOMA-IR (insulin x glucose /22.5).

Secondary outcome was the biological variation of insulin resistance in polycystic ovarian syndrome and controls. Insulin resistance was calculated by HOMA-IR as above, and calculation of biological variation was done on 10 consecutive HOMA-IR taken at 4-day intervals.
Primary outcome measure(s) Comparison of Insulin resistance in polycystic ovarian syndrome and controls
Secondary outcome measure(s) Comparison of biological variation of polycystic ovarian syndrome with controls
Sources of funding Diabetes endowment Fund, University of Hull (UK)
Trial website
Publications
Contact name Prof  Stephen  Atkin
  Address Centre for Diabetes and Endocrinology
220-236 Anlaby Road
  City/town Hull
  Zip/Postcode HU3 2RW
  Country United Kingdom
Sponsor Hull and East Yorkshire Hospitals NHS Trust (UK)
  Address Hull Royal Infirmary
Anlaby Road
  City/town Hull
  Zip/Postcode HU3 2JZ
  Country United Kingdom
Date applied 25/01/2007
Last edited 28/02/2007
Date ISRCTN assigned 28/02/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central